HCV and diabetes: towards a 'sustained' glycaemic improvement after treatment with DAAs?
Clinic of Infectious Diseases, University of Bari, Bari, Italy.
C
C
Fabrizio
Clinic of Infectious Diseases, University of Bari, Bari, Italy.
A
A
Procopio
Scientific Direction, Clinical Epidemiology Unit, IRCCS San Matteo Foundation, Pavia, Italy.
L
L
Scudeller
Clinic of Infectious Diseases, University of Bari, Bari, Italy.
R
R
Dell'Acqua
Clinic of Infectious Diseases, University of Bari, Bari, Italy.
G
G
Bruno
Clinic of Infectious Diseases, University of Bari, Bari, Italy.
E
E
Milano
Clinic of Infectious Diseases, University of Bari, Bari, Italy.
M
M
Milella
Clinic of Infectious Diseases, University of Bari, Bari, Italy. Electronic address: annalisa.saracino@uniba.it.
A
A
Saracino
Clinic of Infectious Diseases, University of Bari, Bari, Italy.
G
G
Angarano
D000998:Antiviral Agents; D001786:Blood Glucose; D003920:Diabetes Mellitus; D019698:Hepatitis C, Chronic; D006801:Humans
D000998:Antiviral Agents; D001786:Blood Glucose